Matches in SemOpenAlex for { <https://semopenalex.org/work/W2941939748> ?p ?o ?g. }
- W2941939748 abstract "Multidrug resistance (MDR) is one of the leading causes of treatment failure in cancer chemotherapy. One major mechanism of MDR is the overexpressing of ABC transporters, whose inhibitors hold promising potential in antagonizing MDR. Glesatinib is a dual inhibitor of c-Met and SMO that is under phase II clinical trial for non-small cell lung cancer. In this work, we report the reversal effects of glesatinib to P-glycoprotein (P-gp) mediated MDR. Glesatinib can sensitize paclitaxel, doxorubicin, colchicine resistance to P-gp overexpressing KB-C2, SW620/Ad300, and P-gp transfected Hek293/ABCB1 cells, while has no effect to their corresponding parental cells and negative control drug cisplatin. Glesatinib suppressed the efflux function of P-gp to [3H]-paclitaxel and it didn't impact both the expression and cellular localization of P-gp based on Western blot and immunofluorescent analysis. Furthermore, glesatinib can stimulate ATPase in a dose-dependent manner. The docking study indicated that glesatinib interacted with human P-gp through several hydrogen bonds. Taken together, c-Met/SMO inhibitor glesatinib can antagonize P-gp mediated MDR by inhibiting its cell membrane transporting functions, suggesting new application in clinical trials." @default.
- W2941939748 created "2019-05-03" @default.
- W2941939748 creator A5003374685 @default.
- W2941939748 creator A5007361731 @default.
- W2941939748 creator A5008998082 @default.
- W2941939748 creator A5012091929 @default.
- W2941939748 creator A5023900879 @default.
- W2941939748 creator A5028992468 @default.
- W2941939748 creator A5044867727 @default.
- W2941939748 creator A5050699960 @default.
- W2941939748 creator A5056661604 @default.
- W2941939748 creator A5061425723 @default.
- W2941939748 creator A5081938413 @default.
- W2941939748 date "2019-04-25" @default.
- W2941939748 modified "2023-10-14" @default.
- W2941939748 title "Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes P-glycoprotein Mediated Multidrug Resistance in Cancer Cells" @default.
- W2941939748 cites W1132077651 @default.
- W2941939748 cites W1517036148 @default.
- W2941939748 cites W1836187494 @default.
- W2941939748 cites W1869276292 @default.
- W2941939748 cites W1981140460 @default.
- W2941939748 cites W2045831118 @default.
- W2941939748 cites W2049392365 @default.
- W2941939748 cites W2049823629 @default.
- W2941939748 cites W2049891139 @default.
- W2941939748 cites W2055634974 @default.
- W2941939748 cites W2064840895 @default.
- W2941939748 cites W2064920658 @default.
- W2941939748 cites W2067491763 @default.
- W2941939748 cites W2076260569 @default.
- W2941939748 cites W2079967238 @default.
- W2941939748 cites W2081775441 @default.
- W2941939748 cites W2088228543 @default.
- W2941939748 cites W2115749410 @default.
- W2941939748 cites W2119010359 @default.
- W2941939748 cites W2124592036 @default.
- W2941939748 cites W2127247883 @default.
- W2941939748 cites W2131487381 @default.
- W2941939748 cites W2156593189 @default.
- W2941939748 cites W2168709731 @default.
- W2941939748 cites W2215668545 @default.
- W2941939748 cites W2346516660 @default.
- W2941939748 cites W2381727044 @default.
- W2941939748 cites W2443453517 @default.
- W2941939748 cites W2461918902 @default.
- W2941939748 cites W2485653171 @default.
- W2941939748 cites W2521344551 @default.
- W2941939748 cites W2552674955 @default.
- W2941939748 cites W2580141764 @default.
- W2941939748 cites W2594755029 @default.
- W2941939748 cites W2594804005 @default.
- W2941939748 cites W2610006399 @default.
- W2941939748 cites W2712679337 @default.
- W2941939748 cites W2740630940 @default.
- W2941939748 cites W2772873089 @default.
- W2941939748 cites W2782382455 @default.
- W2941939748 cites W2782736845 @default.
- W2941939748 cites W2783641815 @default.
- W2941939748 cites W2790939547 @default.
- W2941939748 cites W2792925067 @default.
- W2941939748 cites W2796552195 @default.
- W2941939748 cites W2800108400 @default.
- W2941939748 cites W2895090015 @default.
- W2941939748 cites W2896062486 @default.
- W2941939748 cites W2898119028 @default.
- W2941939748 cites W2900540472 @default.
- W2941939748 cites W2901265038 @default.
- W2941939748 doi "https://doi.org/10.3389/fonc.2019.00313" @default.
- W2941939748 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6494935" @default.
- W2941939748 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31106148" @default.
- W2941939748 hasPublicationYear "2019" @default.
- W2941939748 type Work @default.
- W2941939748 sameAs 2941939748 @default.
- W2941939748 citedByCount "23" @default.
- W2941939748 countsByYear W29419397482019 @default.
- W2941939748 countsByYear W29419397482020 @default.
- W2941939748 countsByYear W29419397482021 @default.
- W2941939748 countsByYear W29419397482022 @default.
- W2941939748 countsByYear W29419397482023 @default.
- W2941939748 crossrefType "journal-article" @default.
- W2941939748 hasAuthorship W2941939748A5003374685 @default.
- W2941939748 hasAuthorship W2941939748A5007361731 @default.
- W2941939748 hasAuthorship W2941939748A5008998082 @default.
- W2941939748 hasAuthorship W2941939748A5012091929 @default.
- W2941939748 hasAuthorship W2941939748A5023900879 @default.
- W2941939748 hasAuthorship W2941939748A5028992468 @default.
- W2941939748 hasAuthorship W2941939748A5044867727 @default.
- W2941939748 hasAuthorship W2941939748A5050699960 @default.
- W2941939748 hasAuthorship W2941939748A5056661604 @default.
- W2941939748 hasAuthorship W2941939748A5061425723 @default.
- W2941939748 hasAuthorship W2941939748A5081938413 @default.
- W2941939748 hasBestOaLocation W29419397481 @default.
- W2941939748 hasConcept C104317684 @default.
- W2941939748 hasConcept C114851261 @default.
- W2941939748 hasConcept C121608353 @default.
- W2941939748 hasConcept C126322002 @default.
- W2941939748 hasConcept C133936738 @default.
- W2941939748 hasConcept C149011108 @default.
- W2941939748 hasConcept C185592680 @default.
- W2941939748 hasConcept C200082930 @default.